Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-25.83	7.56	10.19
Graham Fair Price	-71.08	17.60	60.86
PEG	1878.42	< 0.005	< 0.005
Price/Book	-77.74	0.18	0.83
Price/Cash Flow	-36.26	3.22	-5.06
Prices/Earnings	234.71	0.61	0.18
Price/Sales	-74.11	0.20	0.78
Price/FCF	-36.26	3.22	-5.06
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	14.31	0.22	0.20
Operating Margin	65.48	0.14	0.08
ROA	-92.43	0.02	0.20
ROE	1.13	0.08	-93.35
ROIC	0.07	0.04	-43.22
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.05	-0.34	-84.37
Dividends QOQ	0.00	55.45	100.00
EBIT QOQ	-0.71	0.60	-15.62
EPS QOQ	5.47	-0.93	-83.08
FCF QOQ	-1.61	1.39	-13.44
Revenue QOQ	-0.56	-0.03	94.25
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	56.69	56.84	0.27
Days Sales Outstanding (DSO)	89.26	85.84	-3.83
Inventory Turnover	1.59	1.58	-0.27
Debt/Capitalization	0.61	0.62	1.96
Quick Ratio	0.90	0.96	7.65
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	12.06	13.53	12.15
Cash	6.06	6.86	13.28
Capex	-3.19	-0.43	86.58
Free Cash Flow	-1.97	0.77	-60.83
Revenue	12.81	12.35	-3.58
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.24	1.28	3.19
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	6.57	6.58	0.19
Naive Interpretation	Member

06 - Financial Health · Weak

Rating